The study, «Lenalidomide (LEN) maintenance (MNTC) after high -
dose melphalan and autologous stem cell transplant (ASCT) in
multiple myeloma (MM): A meta - analysis (MA) of overall survival (OS),» is ASCO 2016 abstract no. 8001 and will be discussed during the Hematologic Malignancies — Plasma Cell Dyscrasia
oral abstract session Friday, June 3.